Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4274/tjh.galenos.2021.2021.0277 http://scihub22266oqcxt.onion/10.4274/tjh.galenos.2021.2021.0277 34308605!8656133!34308605     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Turk+J+Haematol 2021 ; 38 (4): 321-324 Nephropedia Template TP {{tp|p=34308605|t=2021. Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study |pdf=|usr=}}{{34308605}} gab.com Text Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study JO: Turk J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=34308605 #FOAvip OBJECTIVE: The aim of this study is to investigate post-COVID-19 antibody titers in patients who received convalescent plasma (CP) in addition to standard-of-care treatment. MATERIALS AND METHODS: Hospitalized COVID-19 patients who received CP in addition to standard care were retrospectively investigated. Patients who received CP with a recorded total COVID-19 antibody test result after treatment were included. From among hospitalized COVID-19 patients who received only standard care with a recorded total COVID-19 antibody test result, a control group matched for age, gender, and comorbidities was formed. Total COVID-19 antibody index levels were compared. RESULTS: Thirty-three CP recipients were enrolled in the study. The control group consisted of 34 age-, gender-, and comorbidity-matched standard-care patients. Median total COVID-19 antibody index levels were significantly reduced in the CP group. CONCLUSION: Although CP therapy may have benefits for disease outcome, its potential ability to hamper long-term immunity may be a problem. Twit Text FOAVip Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study ????Turk J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=34308605 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34308605 #FOAvip English Wikipedia <ref>{{Cite pmid|34308605}}</ref> Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study #MMPMID34308605 Omma A; Erden A; Guven SC; Ates I; Kucuksahin O Turk J Haematol 2021[Dec]; 38 (4): 321-324 PMID34308605show ga OBJECTIVE: The aim of this study is to investigate post-COVID-19 antibody titers in patients who received convalescent plasma (CP) in addition to standard-of-care treatment. MATERIALS AND METHODS: Hospitalized COVID-19 patients who received CP in addition to standard care were retrospectively investigated. Patients who received CP with a recorded total COVID-19 antibody test result after treatment were included. From among hospitalized COVID-19 patients who received only standard care with a recorded total COVID-19 antibody test result, a control group matched for age, gender, and comorbidities was formed. Total COVID-19 antibody index levels were compared. RESULTS: Thirty-three CP recipients were enrolled in the study. The control group consisted of 34 age-, gender-, and comorbidity-matched standard-care patients. Median total COVID-19 antibody index levels were significantly reduced in the CP group. CONCLUSION: Although CP therapy may have benefits for disease outcome, its potential ability to hamper long-term immunity may be a problem. |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Antibody Formation[MESH] |COVID-19 Serotherapy[MESH] |COVID-19/blood/*diagnosis/*therapy[MESH] |Case-Control Studies[MESH] |Cross-Sectional Studies[MESH] |Female[MESH] |Hospitalization[MESH] |Humans[MESH] |Immunization, Passive[MESH] |Male[MESH] |Middle Aged[MESH] |Retrospective Studies[MESH] |SARS-CoV-2/*isolation & purification[MESH]Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: (epmc).pdf DeepDyve Pubget Overpricing